| pubmed-article:1712340 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1712340 | lifeskim:mentions | umls-concept:C0166049 | lld:lifeskim |
| pubmed-article:1712340 | lifeskim:mentions | umls-concept:C2754997 | lld:lifeskim |
| pubmed-article:1712340 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:1712340 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:1712340 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1712340 | pubmed:dateCreated | 1991-8-12 | lld:pubmed |
| pubmed-article:1712340 | pubmed:abstractText | To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patients with chronic non-A, non-B hepatitis for IgG and IgM antibody to hepatitis C virus. IgG antibody to hepatitis C virus was detected in 93% of acute cases and 91% of chronic cases. Of the 101 patients with IgG antibody to hepatitis C virus, 57% had IgM antibody to hepatitis C virus. None of the 20 healthy subjects or 40 patients with acute or chronic hepatitis A or hepatitis B had IgM antibody to hepatitis C virus. At the onset of clinical symptoms in acute hepatitis C, IgG antibody to hepatitis C virus was detected in 8 (57%) and IgM antibody to hepatitis C virus in 9 of 14 patients (64%). Eventually, both IgG and IgM antibody to hepatitis C virus became detectable in 13 of 14 patients with acute hepatitis C. Seven patients with antibody to hepatitis C virus resolved the acute infection within 6 mo and all seven cleared IgM antibody to hepatitis C virus, whereas two cleared IgG antibody to hepatitis C virus. Six patients had a chronic outcome of the acute infection and IgM antibody to hepatitis C virus persisted in detectable amounts for more than 6 mo in all (mean = 15.5 mo). Among 88 patients with chronic non-A, non-B hepatitis with IgG antibody to hepatitis C virus, IgM antibody to hepatitis C virus was detected in 45 (51%).(ABSTRACT TRUNCATED AT 250 WORDS) | lld:pubmed |
| pubmed-article:1712340 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1712340 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1712340 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1712340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1712340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1712340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1712340 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1712340 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:1712340 | pubmed:issn | 0270-9139 | lld:pubmed |
| pubmed-article:1712340 | pubmed:author | pubmed-author:BartoloméJJ | lld:pubmed |
| pubmed-article:1712340 | pubmed:author | pubmed-author:CarreñoVV | lld:pubmed |
| pubmed-article:1712340 | pubmed:author | pubmed-author:QuirogaJ AJA | lld:pubmed |
| pubmed-article:1712340 | pubmed:author | pubmed-author:PorresJ CJC | lld:pubmed |
| pubmed-article:1712340 | pubmed:author | pubmed-author:CampilloM LML | lld:pubmed |
| pubmed-article:1712340 | pubmed:author | pubmed-author:CatilloII | lld:pubmed |
| pubmed-article:1712340 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1712340 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:1712340 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1712340 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1712340 | pubmed:pagination | 38-43 | lld:pubmed |
| pubmed-article:1712340 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:meshHeading | pubmed-meshheading:1712340-... | lld:pubmed |
| pubmed-article:1712340 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1712340 | pubmed:articleTitle | IgM antibody to hepatitis C virus in acute and chronic hepatitis C. | lld:pubmed |
| pubmed-article:1712340 | pubmed:affiliation | Department of Gastroenterology, Fundación Jiménez Díaz, Madrid, Spain. | lld:pubmed |
| pubmed-article:1712340 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1712340 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1712340 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1712340 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1712340 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1712340 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1712340 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1712340 | lld:pubmed |
